GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » G Medical Innovations Holdings Ltd (OTCPK:GMVDF) » Definitions » Gross Margin %

G Medical Innovations Holdings (G Medical Innovations Holdings) Gross Margin % : 259.61% (As of Dec. 2022)


View and export this data going back to 2017. Start your Free Trial

What is G Medical Innovations Holdings Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. G Medical Innovations Holdings's Gross Profit for the six months ended in Dec. 2022 was $5.70 Mil. G Medical Innovations Holdings's Revenue for the six months ended in Dec. 2022 was $2.20 Mil. Therefore, G Medical Innovations Holdings's Gross Margin % for the quarter that ended in Dec. 2022 was 259.61%.


The historical rank and industry rank for G Medical Innovations Holdings's Gross Margin % or its related term are showing as below:


GMVDF's Gross Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 52.83
* Ranked among companies with meaningful Gross Margin % only.

G Medical Innovations Holdings had a gross margin of 259.61% for the quarter that ended in Dec. 2022 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for G Medical Innovations Holdings was 0.00% per year.


G Medical Innovations Holdings Gross Margin % Historical Data

The historical data trend for G Medical Innovations Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G Medical Innovations Holdings Gross Margin % Chart

G Medical Innovations Holdings Annual Data
Trend Sep16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross Margin %
Get a 7-Day Free Trial -31.65 -4.04 13.61 30.42 17.74

G Medical Innovations Holdings Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.21 39.01 18.07 -221.09 259.61

Competitive Comparison of G Medical Innovations Holdings's Gross Margin %

For the Medical Instruments & Supplies subindustry, G Medical Innovations Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G Medical Innovations Holdings's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, G Medical Innovations Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where G Medical Innovations Holdings's Gross Margin % falls into.



G Medical Innovations Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

G Medical Innovations Holdings's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )=Gross Profit (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=0.8 / 4.42
=(Revenue - Cost of Goods Sold) / Revenue
=(4.42 - 3.636) / 4.42
=17.74 %

G Medical Innovations Holdings's Gross Margin for the quarter that ended in Dec. 2022 is calculated as


Gross Margin % (Q: Dec. 2022 )=Gross Profit (Q: Dec. 2022 ) / Revenue (Q: Dec. 2022 )
=5.7 / 2.196
=(Revenue - Cost of Goods Sold) / Revenue
=(2.196 - -3.505) / 2.196
=259.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


G Medical Innovations Holdings  (OTCPK:GMVDF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

G Medical Innovations Holdings had a gross margin of 259.61% for the quarter that ended in Dec. 2022 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


G Medical Innovations Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of G Medical Innovations Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


G Medical Innovations Holdings (G Medical Innovations Holdings) Business Description

Traded in Other Exchanges
N/A
Address
5 Oppenheimer Street, Rehovot, ISR, 7670105
G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.
Executives
Awm Investment Company, Inc. 10 percent owner 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022

G Medical Innovations Holdings (G Medical Innovations Holdings) Headlines